Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)

ClinicalTrials.gov ID: NCT00256750

Public ClinicalTrials.gov record NCT00256750. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 5:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn if Belatacept can provide protection from organ rejection following kidney transplantation while avoiding some of the toxic effects of standard immunosuppressive medications such as kidney damage. Effects on kidney function and patient survival as well as drug safety will also be studied.

Study identification

NCT ID
NCT00256750
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
738 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
May 31, 2008
Completion
Mar 31, 2015
Last update posted
Aug 18, 2016

2005 – 2015

United States locations

U.S. sites
34
U.S. states
23
U.S. cities
32
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35294
Loma Linda University Medical Center-Transplantation Institu Loma Linda California 92354
Cedars Sinai Medical Center Los Angeles California 90048
California Institute Of Renal Research San Diego California 92123
University Of California San Francisco Medical Center San Francisco California 94143
University Of Colorado Health Sciences Center Aurora Colorado 80045
Yale University School Of Medicine-Yale New Haven Hospital New Haven Connecticut 06520
Piedmont Hospital Atlanta Georgia 30309
Emory University Hospital Atlanta Georgia 30322
Medical College Of Georgia Augusta Georgia 30912
University Of Chicago Hospitals Chicago Illinois 60637
University Of Iowa Hospitals And Clinics Iowa City Indiana 52242
University Of Kentucky Lexington Kentucky 40536
Maine Tranplant Program Portland Maine 04102
Western New England Renal & Transplant Associates, Pc Springfield Massachusetts 01107
Henry Ford Hospital, Transplant Institute Detriot Michigan 48202
University Of Minnesota Minneapolis Minnesota 55455
Washington University School Of Medicine St Louis Missouri 63110
Recanati/Miller Transplantation Institute New York New York 10029
Columbia University College Of Physicians & Surgeons New York New York 10032
University Of Rochester Medical Center Rochester New York 14642
University Of North Carolina At Chapel Hill Chapel Hill North Carolina 27599
Carolinas Medical Center Charlotte North Carolina 28203
Duke University Medical Center Durham North Carolina 27710
Div Of Multi-Organ Trans, Hepato-Biliary-Pancreatic Surgery Philadelphia Pennsylvania 19102
Musc Charleston South Carolina 29425
Vanderbilt University Medical Center Nashville Tennessee 27232
Baylor University Medical Center Dallas Texas 75246
Fletcher Allen Health Care Burlington Vermont 05401
Inova Transplant Center Fairfax Virginia 22031
Swedish Medical Center Seattle Washington 98104
Sacred Heart Medical Ctr Providence Medical Research Ctr Spokane Washington 99204
University Of Wisconsin Madison Wisconsin 53792
Froedtert Memorial Lutheran Hospital Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00256750, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2016 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00256750 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →